The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1701
ISSUE1701
April 29, 2024
Intravenous Acetaminophen/Ibuprofen (Combogesic IV)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Intravenous Acetaminophen/Ibuprofen (Combogesic IV)
April 29, 2024 (Issue: 1701)
The FDA has approved Combogesic IV (Hikma), an IV
solution containing acetaminophen and ibuprofen, to
treat mild to moderate pain (alone) or moderate to
severe pain (in combination with an opioid) in adults
when IV analgesia is considered...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.